You
← Back to results
LB
Lexaria Bioscience Corp.Company · Health · A1
RealCurrent
Mission statement · Company scope

“Our mission is to obtain FDA approval for a DehydraTECH – CBD drug for use on hypertension.”

MissionProduct offeringLeads with productClimate & health
✎ Write one like this
In use2023 – now1 sighting
First seenMay 2023Added
Last seenMay 2023Latest observation
Date created—Not published by the organization
Record
Kind
Mission
Scope
Company
Style
Product offering (primary)
Leads with
Product
Best for
Climate & health
Formula
We make [product] for [who]
Tone
Plain
Length
17 words · reading grade 9.8
Review status
unreviewed · classifier rules-v0
Quality score
0.73
Record
st_1e918eb4e1728e3b
Classification confidence
0.50
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2023-05-10 · sec_sentence · 424B4 · accession 0001640334-23-000798
View filing ↗
Report an issueReports are reviewed within 3 working days.
0 to compareCompare